跳至主要内容
临床试验/JPRN-UMIN000042872
JPRN-UMIN000042872已完成未知

Development and evaluation of Gaucher disease (GD) - specific patient reported outcome measurement (PROM) in Japan. - Development and evaluation of Gaucher disease (GD) - specific patient reported outcome measurement (PROM) in Japan.

Takeda Pharmaceutical Company Limited0 个研究点目标入组 8 人开始时间: 2020年12月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
8

研究概览

简要总结

Three main themes emerged from qualitative analysis of patient interviews: treatment status, patient burden, and social support systems. Commonly used words and the relationships between words identified through the hierarchical cluster and co-occurrence network analyses supported these themes and topics. These themes and topics were specific to patients with types 2 and 3 GD and will be used to inform the development of a HRQOL questionnaire specifically for patients with all GD types

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients: - Patients who have cognitive disabilities, - Patients who lack of fluency in Japanese. Caregivers: - Persons with cognitive disabilities - Persons with lack of fluency in Japanese

研究者

相似试验

Development and evaluation of Gaucher disease (GD) -... | 临床试验